Oxervate (CENEGERMIN-BKBJ) 0.002% OPH solution
Ended Awarded
- Contract number
- 36C24525N0353
- Awardee
-
Dompe U.s. Inc. UEI ECCDSKQAN2J3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $39,774
Award facts
- Contract value 100% obligated
- $39,774.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Dompe U.S. Inc., a foreign-owned pharmaceutical manufacturer, to provide Oxervate (cenegermin-bkbj) 0.002% ophthalmic solution. The $39,774.12 order was placed against Dompe's existing General Services Administration (GSA) Pharmaceutical and Drugs Schedule contract (FSS-61-IB). Oxervate is an ophthalmic product used to treat neurotrophic keratitis. This order does not have a set-aside designation. Dompe also holds a $2.4 million Blanket Purchase Agreement with the VA National Acquisition Center specifically for Oxervate, as well as a $5 million FSS Schedule contract to provide pharmaceuticals more broadly. These contracts allow the VA to efficiently procure critical ophthalmic medications to meet the healthcare needs of veterans.
Quick answers
Who was awarded contract 36C24525N0353?
36C24525N0353 was awarded to Dompe U.s. Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on February 5, 2025.
How much is contract 36C24525N0353 worth?
The government has obligated $39,774 on 36C24525N0353.
Is contract 36C24525N0353 an order under another contract?
Yes. 36C24525N0353 is a delivery order under 36F79720D0017, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0353 competed?
The extent of competition for 36C24525N0353 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award